실시간
Clinical OMICsInfant Brain Development Sheds Light on Parkinson’s Link with AutismClinical OMICsAlzheimer’s Genetic Risk Loci: 16 New CandidatesEndpoints NewsActing FDA commissioner pledges to prevent political interference in rare disease meetingEndpoints NewsDimension seeks up to $750M for third life sciences fund after string of successEndpoints NewsElevance talks 'practical' AIEndpoints NewsMammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once againFierceBiotechAutobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2Lonza NewsLonza, Stipple Bio Sign ADC Licensing Deal - Contract PharmaEndpoints NewsHikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drugCellPaleogenomes reveal the evolutionary relationship between modern and cave lionsEndpoints NewsLilly, Boehringer retrench in Germany on proposed health spending cutsEndpoints NewsSupreme Court sides with Hikma in 'skinny label' case
FierceBiotech 2026년 4월 20일

Odyssey charts fresh voyage to public markets after abandoning IPO plans last year

Odyssey charts fresh voyage to public markets after abandoning IPO plans last year

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.